Connection
Whitney High to Biomarkers, Tumor
This is a "connection" page, showing publications Whitney High has written about Biomarkers, Tumor.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.326 |
|
|
|
-
Clarke LE, Mabey B, Flake Ii DD, Meek S, Cassarino DS, Duncan LM, High WA, Napekoski KM, Prieto VG, Tetzlaff MT, Vitale P, Elder DE. Clinical validity of a gene expression signature in diagnostically uncertain neoplasms. Per Med. 2020 09; 17(5):361-371.
Score: 0.102
-
High WA. Detection of Genetic Aberrations in the Assessment and Prognosis of Melanoma. Dermatol Clin. 2017 Oct; 35(4):525-536.
Score: 0.083
-
Suarez A, High WA. Immunohistochemical analysis of KBA.62 in 18 neurothekeomas: a potential marker for differentiating neurothekeoma, but a marker that may lead to confusion with melanocytic tumors. J Cutan Pathol. 2014 Jan; 41(1):36-41.
Score: 0.065
-
Hoang MP, Dresser KA, Kapur P, High WA, Mahalingam M. Microcystic adnexal carcinoma: an immunohistochemical reappraisal. Mod Pathol. 2008 Feb; 21(2):178-85.
Score: 0.043
-
Aran BM, Burton R, High WA, Gru AA. Null T-cell phenotype mycosis fungoides with aberrant CD20 and CD56 expression: A diagnostic dilemma. J Cutan Pathol. 2024 Aug; 51(8):614-617.
Score: 0.033